Milyon USD cinsinden finanslar. Mali yıl Şubat - Ocak'tır.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Hasılat
699
687
673
820
744
714
Hasılat Artışı (YoY)
3%
2%
-18%
10%
4%
2%
Satınalma Maliyeti
334
306
293
370
380
341
Brüt Kâr
365
381
379
450
364
373
Satış, Genel ve İdari
316
314
331
339
300
332
Araştırma ve Geliştirme
22
26
27
30
32
34
İşletme Giderleri
334
336
372
374
347
419
Diğer Finansman Gelirleri (Giderleri)
--
--
--
--
--
--
Kâr Öncesi Gelir
-487
-403
-7
65
5
-60
Kira Vergisi Gideri
-19
-17
2
14
0
-33
Net Kâr
-468
-392
-61
50
5
-27
Net Income Growth
Kâr Artışı
-3,220%
543%
-222%
900%
-119%
-40%
Dolaşım Daki Hisse Senetleri (Dilüte Edilmiş)
46.4
46
46.6
47.3
48.6
47.8
Hisse Değişimi (Yıllık Üst Üste)
-1%
-1%
-1%
-3%
2%
0%
EPS (Diluted)
-10.1
-8.52
-1.32
1.07
0.11
-0.57
EPS Artışı
-3,161%
545%
-223%
873%
-119%
-41%
Öz sermaye akışı
74
82
14
71
66
-22
Hisse Başı Öz Kaynak Akışı
--
--
--
--
--
--
Brüt Karşılık
52.21%
55.45%
56.31%
54.87%
48.92%
52.24%
Faaliyet Kâr Marjı
4.43%
6.4%
1.04%
9.26%
2.15%
-6.44%
Kâr Marjı
-66.95%
-57.05%
-9.06%
6.09%
0.67%
-3.78%
Özsermaye Karlılık Oranı
10.58%
11.93%
2.08%
8.65%
8.87%
-3.08%
EBITDA
71
89
53
123
54
-4
EBITDA Marjinali
10.15%
12.95%
7.87%
15%
7.25%
-0.56%
D&A EBITDA için
40
45
46
47
38
42
Faaliyet Kârı
31
44
7
76
16
-46
Faaliyet Kâr Marjı
4.43%
6.4%
1.04%
9.26%
2.15%
-6.44%
Verilen Vergi Oranı
3.9%
4.21%
-28.57%
21.53%
0%
55%
Önemli İstatistikler
Önceki Kapanış
$14.76
Açılış fiyatı
$14.83
Günün Aralığı
$14.83 - $15.21
52 haftalık aralık
$9.3 - $17.31
İşlem hacmi
411.1K
Ort.Hacim
556.4K
EPS (TTM)
-10.18
Dividend yield
--
Piyasa Değeri
$691.6M
AVNS nedir?
Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company is headquartered in Alpharetta, Georgia and currently employs 2,227 full-time employees. The company went IPO on 2014-10-21. The company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. The company also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.